Stefan Irion - From Dopamine Neurons to 1,700 Transcription Factors: Turning Biology into Companies

Join us for an exciting session with Dr. Stefan Irion, an accomplished biotech executive and scientist who has spent nearly two decades bridging cutting-edge research, therapeutic development, and biotech leadership.

Stefan is currently Chief Scientific Officer at GC Therapeutics and previously served as CSO at BlueRock Therapeutics, where he helped advance innovative cell therapies toward clinical application. His career has taken him from academic research at Memorial Sloan Kettering Cancer Center to leadership roles in the biotech industry, including work on a pioneering stem cell therapy for Parkinson's disease.

Stefan will share firsthand experiences, lessons learned, and practical advice for researchers considering their own entrepreneurial journey.

We look forward to seeing you there!